AHA Scientific Sessions 2025 Abstract

Real-World Effectiveness of Evolocumab in Reducing Major Adverse Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

By Ran Jin, Kathleen E. Hurwitz, Shia T. Kent, Edward Chia-Cheng Lai

Study in peopleInterventions

The paper

Ran Jin, Kathleen E. Hurwitz, Shia T. Kent, Edward Chia-Cheng Lai

Amgen (United States); National Cheng Kung University

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4363106

doi.org/10.1161/circ.152.suppl_3.4363106

American Journal of Preventive Cardiology4 Oct 2026
Most US adults meeting PREVENT risk thresholds lack lipid therapy